TY  - GEN
AU  - Sessa,C
AU  - Cresta,S
AU  - Cerny,T
AU  - Baselga,J
AU  - Rota Caremoli,E
AU  - Malossi,A
AU  - Hess,D
AU  - Trigo,J
AU  - Zucchetti,M
AU  - D'Incalci,M
AU  - Zaniboni,A
AU  - Capri,G
AU  - Gatti,B
AU  - Carminati,P
AU  - Zanna,C
AU  - Marsoni,S
AU  - Gianni,L
TI  - Concerted escalation of dose and dosing duration in a phase I study of the oral camptothecin gimatecan (ST1481) in patients with advanced solid tumors
SN  - 0923-7534
PY  - 2007///0810
KW  - Administration, Oral
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents, Phytogenic
KW  - administration & dosage
KW  - Camptothecin
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Europe
KW  - Female
KW  - Half-Life
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasms
KW  - drug therapy
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/annonc/mdl418
ER  -